SKN | M Evo Global Acquisition II Files for $225 Million IPO to Target US Critical Minerals
M Evo Global Acquisition II, a newly formed special purpose acquisition company, has filed for an initial public offering seeking to raise up to...
Invea Therapeutics Reenters IPO Market With $35 Million Raise Target as Biotech Window Reopens
Invea Therapeutics, a clinical-stage biotechnology company focused on inflammatory diseases, has refiled for an initial public offering seeking to raise up to $35 million....
SKN | Polestar Targets Public Market Growth as EV Maker Reinforces Its IPO Legacy
Lead ParagraphPolestar Automotive Holding UK PLC, the Swedish electric vehicle manufacturer, continues to build on its public-market debut as investors reassess the long-term potential...
SKN | EverCommerce (EVCM) Navigates SaaS Growth Challenges as Governance Risks Remain Elevated
Market Snapshot
EverCommerce Inc. operates in the competitive SaaS infrastructure space, providing mission-critical software solutions to service-based small and medium-sized businesses. While the company benefits...
SKN | Medline’s $5 Billion IPO Closes the 2025 New Issues Market as Eyes Turn to a Blockbuster 2026
Medline’s long-anticipated public debut has officially marked the end of the 2025 IPO season. The private equity–backed medical supplies giant began trading on Nasdaq...